These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5744593)

  • 21. [Effect of ethanolic extract from root tuber of Polygonum multiflorum Thunb. on liver and brain monoamine oxidase in senescence-accelerated mice in vivo].
    Yang X
    Zhongguo Zhong Yao Za Zhi; 1996 Jan; 21(1):48-9, inside back cover. PubMed ID: 8703355
    [No Abstract]   [Full Text] [Related]  

  • 22. [Variations in orientation of metabolic routes due to biochemical and ultrastructural changes induced by pharmacologic agents acting on rat liver oxido-reduction state (Ag 310, Ag 307 and vitamin K)].
    Ornellas MR; Thuret F; Laborit H
    Agressologie; 1969; 10(3):265-75. PubMed ID: 5361357
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the mechanisms of potentiation of the hypnotic effect of some barbiturates by chlorazicin, spasmsolytin and aminazine].
    Vikhliaev IuI; Avakumov VM
    Farmakol Toksikol; 1967; 30(3):283-6. PubMed ID: 4386183
    [No Abstract]   [Full Text] [Related]  

  • 24. [Does potentiation of the excito-motor effects of tryptamine in the rat and mouse enable one to measure the action of monoamine oxidase inhibitors?].
    Denys A; Levy J; Michel-Ber E
    J Physiol (Paris); 1965; 57(4):457-74. PubMed ID: 5850025
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug incompatibilities. Monoamine oxidase inhibitors.
    Glover J
    Br Dent J; 1967 Oct; 123(7):315-20. PubMed ID: 5233493
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potentiation of barbiturates by desipramine in the mouse: mechanism of action.
    Shah HC; Lal H
    J Pharmacol Exp Ther; 1971 Nov; 179(2):404-9. PubMed ID: 5133609
    [No Abstract]   [Full Text] [Related]  

  • 28. Potentiation of morphine & pethidine analgesia by some monoamine oxidase inhibitors in albino rats.
    Bhattacharya SK; Raina MK; Banerjee D; Neogy NC
    Indian J Exp Biol; 1971 Apr; 9(2):257-9. PubMed ID: 5092743
    [No Abstract]   [Full Text] [Related]  

  • 29. [Interactions between drugs used in anesthesia-resuscitation in the pre-, per- and postoperative stages and various types of drugs].
    Lareng L
    Minerva Anestesiol; 1972 Feb; 38(2):81-125. PubMed ID: 4151745
    [No Abstract]   [Full Text] [Related]  

  • 30. [Relations between the antidepressive effects of octamoxine revealed by 3 pharmacological tests and inhibition of cerebral monoamine oxidase in mice].
    Levy J; Michel-Ber E
    Therapie; 1966; 21(4):929-45. PubMed ID: 5925088
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanism of inhibition of beef liver mitochondrial monoamine oxidase by iproniazid.
    Gomes B
    Indian J Biochem Biophys; 1983 Apr; 20(2):96-9. PubMed ID: 6671669
    [No Abstract]   [Full Text] [Related]  

  • 32. Selective monoamine oxidase inhibitors. II. 4-aminophenylalkylamine derivatives.
    Florvall L; Ask AL; Ross SB; Ogren SO; Holm AC
    Acta Pharm Suec; 1983; 20(4):255-70. PubMed ID: 6605662
    [No Abstract]   [Full Text] [Related]  

  • 33. FA-70, a novel selective and irreversible monoamine oxidase-A inhibitor: effect on monoamine metabolism in mouse cerebral cortex.
    Morón JA; Pérez V; Pastó M; Lizcano JM; Unzeta M
    J Pharmacol Exp Ther; 2000 Feb; 292(2):788-94. PubMed ID: 10640319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Modification of mitochondrial monoamine oxidase activity by certain amine inhibitors].
    Baumanis EA; Kalninia IE; Iriste AA; Gorkin VZ
    Vopr Med Khim; 1981; 27(1):72-7. PubMed ID: 6781140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoamine oxidase and head-twitch response in mice. Mechanisms of alpha-methylated substrate derivatives.
    Nakagawasai O; Arai Y; Satoh SE; Satoh N; Neda M; Hozumi M; Oka R; Hiraga H; Tadano T
    Neurotoxicology; 2004 Jan; 25(1-2):223-32. PubMed ID: 14697897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Potentiation by monoamine oxidase inhibitors of the pressor effect of tyramine and of alpha-methyl-m-tyramine].
    Gessa GL
    Arch Ital Sci Farmacol; 1964; 14(3):275-9. PubMed ID: 5880662
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Problems raised by combinations of toxic agents].
    Gaultier M; Gervais P
    Minerva Anestesiol; 1972 Apr; 38(4):259-66. PubMed ID: 4671400
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives.
    Palaska E; Aydin F; Uçar G; Erol D
    Arch Pharm (Weinheim); 2008 Apr; 341(4):209-15. PubMed ID: 18266289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of the activity of an indirect anticoagulant by a monoamine oxidase inhibitor].
    Reber K; Studer A
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):83-7. PubMed ID: 16955968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.